Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS - Lalezari, S.; Martinowitz, U.; Windyga, J.; Enriquez, M. M.; Delesen, H.; Schwartz, L.; Scharrer, I. (Haemophilia : the official journal of the World Federation of Hemophilia, 2014)
Keywords: Adolescent; Adult; age; Age Factors; Aged; Blood Coagulation Tests; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; factor VIII; Factor VIII - administration & dosage; Factor VIII - therapeutic use; Hemophilia A - blood; Hemophilia A - drug therapy; Hemorrhage - blood; Hemorrhage - etiology; Hemorrhage - metabolism; Humans; Male; Middle Aged; Original; pharmacokinetics; Premedication; Severity of Illness Index; Sucrose - administration & dosage; Sucrose - therapeutic use; Treatment Outcome; von Willebrand factor; von Willebrand Factor - immunology; von Willebrand Factor - metabolism; Young Adult; pharmacokinetics; factor VIII; von Willebrand factor; age